Product References
Rapid generation of monocyte-derived antigen-presenting cells with dendritic cell-like properties.
Transfusion
Cunningham S,Hackstein H
Tue Jun 01 00:00:00 EDT 2021
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer.
Cell
Zhang L,Li Z,Skrzypczynska KM,Fang Q,Zhang W,O'Brien SA,He Y,Wang L,Zhang Q,Kim A,Gao R,Orf J,Wang T,Sawant D,Kang J,Bhatt D,Lu D,Li CM,Rapaport AS,Perez K,Ye Y,Wang S,Hu X,Ren X,Ouyang W,Shen Z,Egen JG,Zhang Z,Yu X
Thu Apr 16 00:00:00 EDT 2020
CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia.
Cell reports
Ramakrishnan R,Peña-Martínez P,Agarwal P,Rodriguez-Zabala M,Chapellier M,Högberg C,Eriksson M,Yudovich D,Shah M,Ehinger M,Nilsson B,Larsson J,Hagström-Andersson A,Ebert BL,Bhatia R,Järås M
300-69 was used in Sample Preparation (FC/FACS) to identify CXCR4 signaling as essential for AML stem cells by protecting them from differentiation independent of CXCL12 stimulation.
Tue May 26 00:00:00 EDT 2020
The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling.
Biology open
Song H,Shen Q,Hu S,Jin J
300-69 was used in In vitro experiments to study whether the proinflammatory cytokine macrophage migration inhibitory factor (MIF) has a role in benign prostatic hyperplasia (BPH) progression.
Thu Nov 12 00:00:00 EST 2020
Growth Factor-like Gene Regulation Is Separable from Survival and Maturation in Antibody-Secreting Cells.
Journal of immunology (Baltimore, Md. : 1950)
Stephenson S,Care MA,Fan I,Zougman A,Westhead DR,Doody GM,Tooze RM
Fri Feb 15 00:00:00 EST 2019
Macrophage Migration Inhibitory Factor Acts as the Potential Target of a Newly Synthesized Compound, 1-(9'-methyl-3'-carbazole)-3, 4-dihydro-β-carboline.
Scientific reports
Ko PH,Shen YC,Murugan K,Huang CW,Sivakumar G,Pal P,Liao CC,Luo KS,Chuang EY,Tsai MH,Lai LC
Thu Feb 14 00:00:00 EST 2019
Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
Oncogene
Castro BA,Flanigan P,Jahangiri A,Hoffman D,Chen W,Kuang R,De Lay M,Yagnik G,Wagner JR,Mascharak S,Sidorov M,Shrivastav S,Kohanbash G,Okada H,Aghi MK
300-69 was used in Cell Culture to study the mechanisms of resistance to anti-angiogenic therapies for cancer such as VEGF neutralizing antibody bevacizumab to show that bevacizumab resistance is driven by reduced migration inhibitory factor (MIF) at the tumor edge causing proliferative expansion of M2 macrophages, which in turn promotes tumor growth.
Thu Jun 29 00:00:00 EDT 2017
Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors.
Journal of immunology (Baltimore, Md. : 1950)
Lourenco S,Teixeira VH,Kalber T,Jose RJ,Floto RA,Janes SM
Wed Apr 01 00:00:00 EDT 2015
Potent Paracrine Effects of human induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells Attenuate Doxorubicin-induced Cardiomyopathy.
Scientific reports
Zhang Y,Liang X,Liao S,Wang W,Wang J,Li X,Ding Y,Liang Y,Gao F,Yang M,Fu Q,Xu A,Chai YH,He J,Tse HF,Lian Q
300-69 was used in In vivo experiments to demonstrate that macrophage migration inhibitory factor (MIF) and growth differentiation factor-15 (GDF-15) in conditioned medium harvested from induced pluripotent stem cell-derived mesenchymal stem cells (iPSC-MSCs-CdM), provide enhanced cardioprotection against anthracycline-induced cardiomyopathy compared to conditioned medium harvested from bone marrow mesenchymal stem cells (BM-MSCs-CdM).
Tue Jun 09 00:00:00 EDT 2015